Labor Onset and Length AbnormalitiesNCT06537089
Comparative Study Between Using WHO Labour Care Guide & Modified WHO Partograph
A study testing Supportive care measures and LCG guided labour interference in people with Labor Onset and Length Abnormalities and 37 or More Completed Weeks of Gestation, run by Hend Mahmoud Abdelghany at 1 site in Egypt.
Trial summary
This randomized clinical trial is based on comparing the efficiency of modified WHO partographs vs. the new WHO labour care guide in monitoring and assessing the outcome of labour. Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Labor Onset and Length Abnormalities, 37 or More Completed Weeks of Gestation, First Birth
- What is being tested?
- Supportive care measures and LCG guided labour interference
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 230 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Aug 2024to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Primiparous women.
- Term gestation between 37 and 40 weeks.
- Maternal age from 18 -35 years
- Body mass index BMI of 18.5 to 29.9 kg/m2
- Cephalic presentation. 6. Active first stage of labour
Who cannot join
- Women with any medical comorbidities, such as (hypertension, diabetes mellitus, renal disease, or pulmonary disease).
- Women with presence of any obstetrical complications, such as preterm birth, multiple gestation, breech presentation, postdated pregnancy, or bad obstetrical history.
- women who were given intrapartum epidural analgesia.
Trial locations and contacts
1 site in 1 country.
Egypt1 site
kasr Al Aini, Faculty of Medicine, Cairo University
Cairo, Old Cairo, 11562
About this study
Official title: Comparative Study Between Using WHO Labour Care Guide & Modified WHO Partograph in Reducing Primary Cesarean Section in Primiparous Women in Active First Stage of Labour.
This randomized clinical trial is based on comparing the efficiency of modified WHO partographs vs. the new WHO labour care guide in monitoring and assessing the outcome of labour.
Read the detailed description
A group of primiparous women in first stage of labour will be randomized into two groups then monitored during first stage of labour. First group will be monitored by modified WHO partograph. The rest of participants will be monitored by WHO labour care Guide. The labour will be monitored regarding progress rate, mode of delivery.
- Conditions
- Labor Onset and Length Abnormalities, 37 or More Completed Weeks of Gestation, First Birth
- Being tested
- Supportive care measures, LCG guided labour interference
- Keywords
- labour Monitoring, primiparous
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Supportive care measuresOther
traditional partograph to properly manage first stage of labor
LCG guided labour interferenceOther
LCG as a new tool to make proper decision and management of first stage of labour
| Study group | Role | What they receive |
|---|---|---|
| WHO labour care guide | Active comparator | Not described Receives: Other: LCG guided labour interference |
| Modified WHO partograph | Active comparator | Not described Receives: Other: Supportive care measures |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of primary caesarean section
number of women will undergo Caesarean section after monitoring, whether by Modified WHO partograph or a labour care Guide
Measured: First and second stage of labour
Secondary outcomes (3)
Duration of active phase of first stage of labour
Measured: First stage of labour
Duration of second stage of labour
Measured: Second stage of labour
need for oxytocin use
Measured: First stage of labour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2024
- Study start1 Aug 2024
- Primary completion30 Dec 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Labor Onset and Length AbnormalitiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 230 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hend Mahmoud Abdelghany
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Hend Mahmoud Abdelghany, Kasr El Aini Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06537089
- Sponsor's protocol ID
- MD-400-2023
- Status last verified
- Feb 2026
- First submitted
- 31 Jul 2024
- Last updated
- 23 Feb 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 23 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Study Between Using WHO Labour Care Guide & Modified WHO Partograph in Reducing Primary Cesarean Section in Primiparous Women in Active First Stage of Labour.
- ClinicalTrials.gov ID
- NCT06537089
- Acronym / sponsor ID
- MD-400-2023
- Conditions
- Labor Onset and Length Abnormalities, 37 or More Completed Weeks of Gestation, First Birth
- Keywords
- labour Monitoring, primiparous
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 230 participants (actual)
- Lead sponsor
- Hend Mahmoud AbdelghanyUniversity, hospital or other
- Study start
- 1 Aug 2024 (actual)
- Primary completion
- 30 Dec 2025 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 5 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized clinical trial is based on comparing the efficiency of modified WHO partographs vs. the new WHO labour care guide in monitoring and assessing the outcome of labour.
Detailed description
A group of primiparous women in first stage of labour will be randomized into two groups then monitored during first stage of labour. First group will be monitored by modified WHO partograph. The rest of participants will be monitored by WHO labour care Guide. The labour will be monitored regarding progress rate, mode of delivery.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| WHO labour care guide | Active comparator | Other: LCG guided labour interference |
| Modified WHO partograph | Active comparator | Other: Supportive care measures |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Primiparous women.
- Term gestation between 37 and 40 weeks.
- Maternal age from 18 -35 years
- Body mass index BMI of 18.5 to 29.9 kg/m2
- Cephalic presentation. 6. Active first stage of labour
Key exclusion criteria (3 listed)
- Women with any medical comorbidities, such as (hypertension, diabetes mellitus, renal disease, or pulmonary disease).
- Women with presence of any obstetrical complications, such as preterm birth, multiple gestation, breech presentation, postdated pregnancy, or bad obstetrical history.
- women who were given intrapartum epidural analgesia.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Supportive care measurestraditional partograph to properly manage first stage of labor | Other | Modified WHO partograph |
| LCG guided labour interferenceLCG as a new tool to make proper decision and management of first stage of labour | Other | WHO labour care guide |
Primary outcome
Rate of primary caesarean section
Time frame: First and second stage of labour
number of women will undergo Caesarean section after monitoring, whether by Modified WHO partograph or a labour care Guide
3 secondary outcomes
Duration of active phase of first stage of labour
Time frame: First stage of labour
Duration of second stage of labour
Time frame: Second stage of labour
need for oxytocin use
Time frame: First stage of labour
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Labor Onset and Length Abnormalities
RecruitingPhase 2
Use of Cinnamomum Verum for Induction of Labor. Double Blind Randomized Clinical Trial
Labor Onset and Length Abnormalities, First Birth
Recruiting
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
Labor Dystocia, Labor Complication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Supportive care measures and LCG guided labour interference in people with Labor Onset and Length Abnormalities and 37 or More Completed Weeks of Gestation, run by Hend Mahmoud Abdelghany at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of primary caesarean section (time frame: First and second stage of labour). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.